#Hyperphosphatemia
Calcium phosphate continents/plates/crystals, AKI, severe hyperphosphatemia. #UrinarySediment #UrineMicroscopy 🔬
November 9, 2024 at 8:51 PM
www.dustri.com/nc/article-r... Fibroblast growth factor receptor inhibitor-induced hyperphosphatemia: Lessons for the nephrologist
November 19, 2024 at 10:15 AM
How many of the causes of "hyperphosphatemia" do you know? https://gamuts.net/x/22501 #radiology #Gamuts #DDx
September 28, 2026 at 7:01 AM
Tenapanor: A Phosphate Absorption Inhibitor for the Management of Hyperphosphatemia in Patients With Kidney Failure ca. 2025
#Nephpearls #NephSky #CKDMBD

👉🏼 pubmed.ncbi.nlm.nih.gov/38992521/
May 5, 2025 at 8:59 PM
Hypophosphatemia and Hyperphosphatemia: Diagnostic work up from @doctorgates.bsky.social
#Nephpearls #NephSky

👉 shop.lww.com/Manual-of-Ne...
May 17, 2026 at 4:40 PM
#Quiz from Feb '22: A 77-year-old man with a history of pulmonary tuberculosis initiated chemotherapy for multiple myeloma. He had elevated gamma fraction and high IgG κ light chain levels. Why does this patient have hyperphosphatemia?

bit.ly/34hZ6JU (FREE)
May 24, 2025 at 10:01 AM
I can’t think of CKDIIIb with hyperphosphatemia!
April 19, 2025 at 4:26 AM
Calcium phosphate “plates” or “continents”, 4x objective, SM stain, bright field, polarized light; acute hyperphosphatemia, AKI, ATN, DKA, shock. #UrinarySediment #UrineMicroscopy @OchsnerNephro @karolas_smile #crystalluria
December 9, 2024 at 8:17 PM
Yes, the treatment of hyperphosphatemia is without a doubt worse than the disease (and never ending) #NephJC
a woman in a red dress is holding a microphone and screaming .
ALT: a woman in a red dress is holding a microphone and screaming .
media.tenor.com
August 6, 2025 at 1:31 AM
Struggling with hyperphosphatemia in dialysis patients? 🦴🫘

Meet #Tenapanor!

It inhibits paracellular phosphate absorption by modulating NHE3 & tight junctions.

A novel way to tackle phosphorus! 🔬💊

#Nephrology #Hyperphosphatemia #Dialysis #HD

📖https://doi.org/10.1053/j.jrn.2024.07.003
March 5, 2025 at 7:01 PM
Can photographic dietary logs help with the management of hyperphosphatemia for patients with kidney failure on dialysis?

Dr. A.J. Lowe and Dr. Tyler Larson, both internal medicien residents at UNMC, worked to answer that question with faculty mentor Dr. Prasanth Ravipati! #NKFClinicals
April 12, 2025 at 4:21 PM
The calcimimetic etelcalcetide restores cardiac function in chronic hyperphosphatemia via calcium sensing receptor–cAMP activation

doi.org/10.1016/j.kint.2026.03.018

#MedSky #NephSky #OpenAccess #cardiovasculardisease
April 30, 2026 at 9:57 PM
Tumour lysis is the expected, and desired, result of anti-cancer therapy. However, the accumulation of solutes from the tumour cells can lead to acute kidney injury, hyperphosphatemia and secondary hypocalcemia.
https://www.nature.c...
August 2, 2025 at 5:43 PM
Alebund Pharmaceuticals Completes Patient Enrollment for AP301 Trial Against Hyperphosphatemia#China#Shanghai#AP301#Hyperphosphatemia#Alebund_Pharmaceutical
Alebund Pharmaceuticals Completes Patient Enrollment for AP301 Trial Against Hyperphosphatemia
Alebund Pharmaceuticals has successfully finished patient enrollment in an important Phase III trial for AP301, aimed at treating hyperphosphatemia in CKD patients.
third-news.com
May 6, 2026 at 4:05 AM
We had a great renal potpourri last week with Dr. Nwankwo discussing an interesting case of pseudo-dyskalemias, Dr. McMillan reviewing the management of hyperphosphatemia in home dialysis, and Dr. Westphal sharing pearls in the work-up & treatment of Nutcracker Syndrome!!!
January 27, 2025 at 5:03 PM

In an open-label Phase 2 trial, oxylanthanum carbonate (OLC), a phosphate binder, was well tolerated and enabled serum phosphate concentration control in over 90% of patients with hyperphosphatemia and a low pill burden. Read more in #ASNCJASN:

kidney.pub/CJASN0780
August 21, 2025 at 6:00 PM
Alebund Pharmaceuticals Initiates Global Phase IIb Trial for AP306 in Treating Hyperphosphatemia#China#Shanghai#Alebund#Hyperphosphatemia#AP306
Alebund Pharmaceuticals Initiates Global Phase IIb Trial for AP306 in Treating Hyperphosphatemia
Alebund Pharmaceuticals has commenced a Phase IIb trial for AP306 aimed at combatting hyperphosphatemia in dialysis patients, marking a significant step in renal healthcare.
third-news.com
July 21, 2026 at 11:13 AM